153200-64-7

Usage

Uses

Used in Pharmaceutical Synthesis:
3-Cyclopropylmethoxy-4-methoxybenzaldehyde is utilized as a starting material in the production of various pharmaceuticals. Its unique structure allows for the creation of a wide range of drug compounds, making it a valuable asset in the field of medicinal chemistry.
Used in Fine Chemicals Production:
In addition to pharmaceuticals, 3-Cyclopropylmethoxy-4-methoxybenzaldehyde is also employed in the synthesis of fine chemicals, which are high-purity chemicals used in various industries, including cosmetics, fragrances, and agrochemicals.
Used in Research and Development:
3-Cyclopropylmethoxy-4-methoxybenzaldehyde is used in research and development processes to explore its potential in the synthesis of new drug compounds. Its unique properties and reactivity make it a promising candidate for the development of innovative pharmaceuticals.
Used in Medicinal Chemistry:
3-Cyclopropylmethoxy-4-methoxybenzaldehyde exhibits potential biological activities, which makes it a valuable resource in medicinal chemistry for the development of new drug candidates. Its ability to be modified and incorporated into various chemical structures allows for the exploration of its therapeutic potential.
Safety Considerations:
It is important to handle 3-Cyclopropylmethoxy-4-methoxybenzaldehyde with care due to its potential health hazards. Proper safety measures should be taken during its synthesis, storage, and use to minimize risks to human health and the environment.

Upstream product

• 621-59-0 isovanillin 
• 5911-08-0 chloro(cyclopropyl)methane 
• 2516-33-8 Cyclopropylmethanol 
• 1972-28-7 diethylazodicarboxylate 
• 7051-34-5 cyclopropylcarbinyl bromide 

Downstream Products

• 153200-65-8 3-(cyclopropylmethoxy)-4-methoxybenzeneacetonitrile 
• 183660-56-2 4-(chloromethyl)-2-(cyclopropylmethoxy)-1-methoxybenzene 

Relevant academic research and scientific papers

ANTI-INFLAMMATORY COMPOUND, AND PREPARATION AND USE THEREOF

The present invention provides an anti-inflammatory compound, which is a compound having a structure (I) as shown below: The compound is a target that is important for autoimmune activation, and that has strong inhibitory effect on PDE4 and penetrates the skin easily, and is a new type anti-inflammatory compound that is easily degraded.

6-phenyltetrahydro-1,3-oxazin-2-one derivative and pharmaceutical composition containing the same

A 6-phenyltetrahydro-1,3-oxazin-2-one derivative having the formula (I): wherein, R1is an unsubstituted or substituted C1to C8alkyl group; an unsubstituted or substituted C3to C7cycloalkyl group;, etc

5-phenyl-3-pyridazinone derivatives and drug composition containing the same

A 5-phenyl-3-pyridazinone derivative having the formula (I) wherein R1represents an unsubstituted or substituted C1to C8alkyl group, C3to C7cycloalkyl group, or indanyl group; R2represents

Use of 2-phenylmorpholin-5-one derivatives

A 2-phenylmorpholin-5-one derivative having the formula (I): wherein R1 represents a C1 to C8 alkyl group, a C3 to C7 cycloalkyl group or an indanyl group, R2 represents a C1 to C4 alkyl group, R3 represents a hydrogen atom, a C1 to C5 alkyl group, etc., R4 represents a hydrogen atom, a C1 to C6 alkyl group, etc., R5, R6 represent a hydrogen atom, a C1 to C5 alkyl group, etc.,an optical isomer thereof or a pharmacologically acceptable salt thereof, or a hydrate or solvate thereof and a pharmaceutical composition containing the same.The above compound has a strong type IV phosphodiesterase (PDE) inhibitory activity and has bronchodilater and antiinflammatory effects.

COMPOUNDS CONTAINING PHENYL LINKED TO ARYL OR HETEROARYL BY AN ALIPHATIC- OR HETEROATOM-CONTAINING LINKING GROUP

This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase

Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group

This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase.

Compounds useful for treating allergic or inflammatory diseases

Novel cyclohexanes of Formulas (I) and (II) STR1 are described herein. They inhibit the production of Tumor Necrosis Factor and are useful in the treatment of disease states mediated or exacerbated by TNF production; these compounds are also useful in the mediation or inhibition of enzymatic or catalytic activity of phosphodiesterase V.